Arai, Shota
Tachibana, Takayoshi https://orcid.org/0000-0002-7780-4459
Izumi, Akihiko
Takeda, Takaaki
Tamai, Yotaro
Sato, Shuku
Hashimoto, Chizuko
Fujimaki, Katsumichi
Ishii, Ryuji
Kabasawa, Noriyuki
Hirasawa, Akira
Inoue, Yasuyuki
Tanaka, Masatsugu
Suzuki, Takahiro
Nakajima, Hideaki
Article History
Received: 27 February 2024
Revised: 10 May 2024
Accepted: 17 May 2024
First Online: 25 May 2024
Declarations
:
: TT reports honoraria from Pfizer, Otsuka, MSD, AbbVie, Chugai, Asahikasei-pharma, and Astellas, Novartis, and Nippon-Shinyaku, outside the submitted work. YT reports honoraria from Sanofi and Chugai, outside the submitted work. TS reports honoraria from Kyowa Kirin, Novartis, Alexion, and Chugai, outside the submitted work. HN reports honoraria from Novartis and Daiichi-Sankyo, scholarships from Daiichi-Sankyo, Celgene, Chugai, Nihon-Shinyaku, Astellas, Asahikasei-pharma, Takeda, Pfizer, and Eisai outside the submitted work.
: The study was approved by the institutional review board of Kanagawa Cancer Center (No. 2023–35) and conducted in accordance with the Helsinki declaration.